CLIA Guidance Allows Firms To Gain Waiver Through User Comparison Studies
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers seeking waived status for diagnostic tests under user-based criteria will need to perform agreement studies with at least 300 untrained users to show that those users obtain the same results as lab professionals, according to an FDA draft guidance issued Jan. 23.
You may also be interested in...
FDA Pulls CLIA Waiver Guidance, CMS To Take Lead Drafting New Criteria
The Centers for Medicare & Medicaid Services will have the authority to make the final call on whether products receive CLIA waiver, according to FDAers.
FDA Pulls CLIA Waiver Guidance, CMS To Take Lead Drafting New Criteria
The Centers for Medicare & Medicaid Services will have the authority to make the final call on whether products receive CLIA waiver, according to FDAers.
HHS Sign-Off Critical To CLIA Waiver Proposal: FDA Criteria At Odds With CMS'
Manufacturers seeking CLIA waivers for in vitro diagnostics should wait until FDA's interim guidance is finalized before using the alternative approach it outlines, according to CDRH.